PATENT CLAIM ANALYSIS

Application Number: 15747860
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "499000"]

Abstract:
The present invention relates to nanocomposites for the controlled delivery of active ingredients into the central nervous system. The nanocomposite according to the present invention comprises a biocompatible core part comprising biodegradable material, and polyelectrolytes able to form a electrostatic van der Waals interactions with the material of the core part. The core part of the nanocomposite is able to bind various pharmaceutical agents. The present invention also relates to a process for the preparation of the nanocomposite according to the present invention and to the use of the nanocomposite according to the present invention.

Claim (Index 4):
The nanocomposite as claimed in  claim 1 , further comprises one of more active ingredients, preferably selected from the following group: kynurenic acid (KYNA), sodium kynurenate, dopamine (DOPA), ibuprofen (IBU); and/or an adjuvant facilitating the crossing of the active ingredient through the blood-brain barrier, preferably vitamin E.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 86.0
- Lexical Diversity: 2.08333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13203603', '10376386', '15788777', '15757475', '11897979']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7218476487102147
- 35 USC 102 Novelty (BERT): 0.4908515223038953
- Combined Prediction Score: 0.6987480360695828
- Mean Citation Score: 167.443654
- Max Citation Score: 174.7844
- Similarity Product: 114.54971228134632

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test